When compared individually to oxytocin, misoprostol, and oxytocin+misoprostol combination, the use of heat-stable carbetocin for PPH prevention resulted in lower costs by 1.7%, 3.5% and 1.0%, respectively. Here, OXT is linked to pulmonary arterial hypertension.